Open Accessibility Menu

Thoracic (Lung/chest)

NRG – S1914 at

A randomized, phase III trial of induction/consolidation atelzolizumab (NSC #783608) + SBRT vs SBRT alone in high-risk, early-stage non-small-cell lung cancer (NSCLC)

Cancer Type: NSCLC, Stage I-IIA, high-risk

Principal Investigator: Dr. Debra Brandt

Please contact Clinical Trials Office for more details: 561-263-5791

  • Jupiter Medical Center

    We want to help you! If you have questions about our services and what we can offer you and your loved ones, please reach out.